Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision label updated to v3.5.0. The previous label v3.4.3 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- Added Revision: v3.4.3 - Deleted Revision: v3.4.2SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now displays 'Revision: v3.4.2' and no longer shows 'Revision: v3.4.1'.SummaryDifference0.0%

- Check49 days agoChange DetectedPlain Language Summary has been added to the Study Details page, and the record shows a new revision (v3.4.1). The previous revision (v3.4.0) was removed and new date entries for 2026-02-05, 2026-01-15, and 2025-12 were added.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded UI controls to show/hide the glossary and updated metadata sections to include Last Update Submitted that Met QC Criteria and Last Update Posted, plus No FEAR Act Data with Revision: v3.4.0. Removed the older labels and the previous revision v3.3.4.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision 3.3.4 was added and Revision 3.3.3 was removed. This change affects only the revision history and does not alter core study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.